NCT01433861

Brief Summary

The choice of surgical strategy for patients with proximal gastric cancer is controversial mainly because proximal gastrectomy is infamous for high rates of reflux symptoms and anastomotic stricture. but there are no prospective randomized trials until now. The primary end point of this study is whether the rate of reflux esophagitis is different or not between LAPG and LATG. Through this study, we

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_3 gastric-cancer

Timeline
Completed

Started Jul 2012

Shorter than P25 for phase_3 gastric-cancer

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 14, 2011

Completed
10 months until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

January 9, 2017

Status Verified

January 1, 2017

Enrollment Period

4 months

First QC Date

September 10, 2011

Last Update Submit

January 6, 2017

Conditions

Keywords

gastric cancerproximal gastrectomytotal gastrectomylaparoscopyreflux esophagitisdouble tract reconstruction

Outcome Measures

Primary Outcomes (3)

  • Rate of reflux esophagitis

    Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score

    postoperative 3 month

  • Rate of reflux esophagitis

    Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score

    postoperative 6 month

  • Rate of reflux esophagitis

    Comprehesive evaulation by 24hr pH monitoring, DISIDA scan, Endoscopic evaluation according to LA classification and Visick score

    postoperative 12 month

Study Arms (2)

LAPG

ACTIVE COMPARATOR

LAPG : laparoscopy-assisted proximal gastrectomy with double tract reconstruction group

Procedure: Laparoscopy-assisted gastrectomy

LATG

ACTIVE COMPARATOR

LATG : laparoscopy-assisted total gastrectomy group

Procedure: Laparoscopy-assisted gastrectomy

Interventions

Laparoscopy-assisted proximal gastrectomy versus Laparoscopy-assisted total gastrectomy

LAPGLATG

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20\~80
  • Informed consent
  • No other malignancies
  • Proximal gastric cancer met by following conditions
  • Lesion located on proximal stomach (upper one third)
  • Lesion below 5cm in size
  • Lesion confined to proper muscle depth (cT2)
  • No evidence of metastatic enlarged LN on #5, 6, 4d, 10 basins and other distant metastasis. (cN1)

You may not qualify if:

  • If patients is only suitable to total gastrectomy, he will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam, Gyenggi, South Korea

Location

MeSH Terms

Conditions

Stomach NeoplasmsEsophagitis, Peptic

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesEsophagitisEsophageal DiseasesGastroenteritisPeptic UlcerDuodenal DiseasesIntestinal Diseases

Study Officials

  • Hyung-Ho Kim, M.D., Ph.D.

    Seoul National University Bundang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 10, 2011

First Posted

September 14, 2011

Study Start

July 1, 2012

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

January 9, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations